Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2025-12-24 @ 1:35 PM
NCT ID:
NCT07004595
Eligibility Criteria:
Inclusion Criteria:
* Patient with fibrosing ILD according to the ATS/ERS/JRS/ALAT 2022 criteria.
* Patient aged ≥ 65 years.
* Outpatient consultation (scheduled appointment in an outpatient clinic, day hospital, or weekly hospital stay).
* French-speaking patient.
* Patient who has received an information sheet explaining the study and has not expressed opposition to participating in this research.
Exclusion Criteria:
* Patient under legal guardianship, curatorship, or judicial protection.
* Cognitive disorders limiting the use of questionnaires.
* Patient with a CT scan showing an early usual interstitial pneumonia (UIP) pattern according to the ATS/ERS/JRS/ALAT 2022 classification.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT07004595
Study Brief:
Protocol Section:
NCT07004595